Artwork

Content provided by Rasmus Køster-Rasmussen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rasmus Køster-Rasmussen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

#35 - Bliver man sund af Wegovy? SELECT-studiet

36:28
 
Share
 

Manage episode 422335398 series 3359268
Content provided by Rasmus Køster-Rasmussen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rasmus Køster-Rasmussen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

I denne episode analyserer vi SELECT studiet fra 2023, som undersøgte om wegovy kan mindske antallet af blodpropper hos patienter der i forvejen var alvorligt hjertesyge. Studiet var et gigantisk lodtrækningsstudie som foregik i over 40 lande - et klassisk 'seeding' som fik udbredt medicinen over hele verden på kort tid. Hvordan skal resultaterne forstås? Lyt med og dan din egen mening.
SELECT-studiet
Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, et al; SELECT Trial Investigators. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023. NEJMoa2307563

  continue reading

37 episodes

Artwork
iconShare
 
Manage episode 422335398 series 3359268
Content provided by Rasmus Køster-Rasmussen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rasmus Køster-Rasmussen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

I denne episode analyserer vi SELECT studiet fra 2023, som undersøgte om wegovy kan mindske antallet af blodpropper hos patienter der i forvejen var alvorligt hjertesyge. Studiet var et gigantisk lodtrækningsstudie som foregik i over 40 lande - et klassisk 'seeding' som fik udbredt medicinen over hele verden på kort tid. Hvordan skal resultaterne forstås? Lyt med og dan din egen mening.
SELECT-studiet
Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, et al; SELECT Trial Investigators. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023. NEJMoa2307563

  continue reading

37 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide